On September 19 and 27, 2016, the US Department of Justice announced two False Claims Act settlements that required corporate executives to make substantial monetary payments to resolve their liability. How will director and executive liability be impacted by the Yates Memo and False Claims Act in an evolving health care climate?
One Year Later: The Yates Memo, False Claims Act and Director & Executive Liability
By Rebecca C. Martin and Tony Maida on October 7, 2016
Posted In Executive Compensation
Rebecca C. MartinRebecca C. Martin has broad experience in investigations, litigations and settlements involving the False Claims Act and other civil health care and financial fraud matters. A 15-year veteran of the United States Attorney’s Office for the Southern District of New York (SDNY), Rebecca most recently served as co-chief of the Civil Frauds Unit and health care fraud coordinator for SDNY. Read Rebecca Martin's full bio.
Tony MaidaTony Maida counsels health care and life sciences clients on government investigations, regulatory compliance and compliance program development. Having served as a government official, Tony has extensive experience in health care fraud and abuse and compliance issues, including the federal and state Anti-Kickback and Stark Laws and Medicare and Medicaid coverage and payment rules. He represents clients in False Claims Act (FCA) qui tam matters, government audits, civil monetary penalty and exclusion investigations, and Centers for Medicare and Medicaid Services (CMS) suspension, and revocation actions, negotiating and implementing corporate integrity agreements, and making government self-disclosures. Read Tony Maida's full bio.
Related Posts
- Surprise Medical Billing Law ‘Not Working the Way We Want It to Work’
- FTC Issues Rule Banning Worker Noncompete Agreements
- Family Office Tax Webinar Replay: Compensation Strategies
- Soaring to New Heights: The IRS’s Crackdown on Aircraft Usage by Corporations and High-Income Earners
- Deadlines for the Adoption of Clawback Policies Extended
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- Complying With the ‘Relevant Data’ Requirement Under the Final 2024 Mental Health Parity and Addiction Equity Act: A Proposal for a Workable Alternative
- HHS Letter Reiterates Expectations for Language Accessibility
- Employee Benefit Plans: Important Considerations for Year-End and 2025
- Post-Election Outlook: Issues to Watch for Pharmacy Industry Stakeholders
- Post-Election Health Policy Priorities
